Scilex Holding Company Common Stock

SCLX

Scilex Holding Company (SCLX) is a specialty pharmaceutical company focused on developing and commercializing innovative pain management and other healthcare products. It aims to deliver targeted medical treatments through research, development, and strategic partnerships in the healthcare sector.

$19.15 0.00 (0.00%)
🚫 Scilex Holding Company Common Stock does not pay dividends

Company News

Scilex Holding Company Announces Closing of Previously Announced Second Tranche Investment in Datavault AI Inc., Completing Its Two-Tranche Equity Financing in Datavault AI Inc.
GlobeNewswire Inc. • Scilex Holding Company • November 26, 2025

Scilex Holding Company completed its second tranche investment in Datavault AI Inc., purchasing a pre-funded warrant for 263,914,094 shares valued at approximately $583.3 million. Both companies plan to collaborate on Real World Asset tokenization in 2026.

Datavault AI Just Raised Guidance by 400%—Are You Paying Attention?
Investing.com • Jeffrey Neal Johnson • November 21, 2025

Datavault AI announced a multi-million dollar agreement with Triton Geothermal, dramatically raising its fiscal year revenue guidance from $12-15 million to $30 million for 2025, and projecting over $200 million for 2026, driven by its real-world asset tokenization technology.

Datavault And New Era Energy: AI Penny Stock Powerhouses
Benzinga • Erica Kollmann • September 26, 2025

Two penny stocks, Datavault AI and New Era Energy & Digital, are experiencing significant momentum in AI and digital infrastructure sectors, with substantial stock price increases and promising technological positioning.

Penny Stocks To Buy This Week? Analysts Like These 3
PennyStocks • J. Samuel • October 9, 2023

Penny stocks to watch this week. The post Penny Stocks To Buy This Week? Analysts Like These 3 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Why Shares of Scilex Are Up Monday
The Motley Fool • [email protected] (Jim Halley) • October 9, 2023

An analyst at H.C. Wainwright initiated coverage on the stock.

Related Companies